3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Solid Tumors
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Nasopharangeal Cancer
1
Lymphoma, T-Cell, Peripheral
1
Lung Neoplasms
1
Kidney Neoplasms
1
Kidney Diseases
1
Hemangiosarcoma
1
Glioma
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
CRC
1
Interventions
fludarabine
4
fludarabine phosphate
3
asciminib
3
venetoclax
2
gilteritinib
2
Whole-Body Irradiation
2
Tacrolimus
2
Idarubicin
2
Cytarabine
2
Cyclophosphamide
2
Busulfan
2
Bone Marrow Transplantation
2
ponatinib
1
nilotinib
1
enasidenib
1
blinatumomab
1
aldesleukin
1
Thiotepa
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Mycophenolic Acid
1
Methotrexate
1
Mesna
1
Melphalan
1
Interleukin-2
1
Imatinib Mesylate
1
Hyperbaric Oxygenation
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid
×
spartalizumab
×
90 days
×
Clear all
No trials found.